Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MISSISSAUGA, Ontario, March 31, 2026 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (“Next Hydrogen”) (TSXV:NXH), a leading Canadian designer and manufacturer of hydrogen electrolyzers, reports...
-
JERSEY CITY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address...
-
MONTREAL, March 30, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), a leader in ultra-high temperature processes & engineering...
-
AIRJ Achieves 2025 Objectives Across Technology Validation, Product Development, and Strategic Partnerships RONAN, Mont., March 30, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation...
-
New York, NY, March 30, 2026 (GLOBE NEWSWIRE) -- Future Money Acquisition Corporation (NASDAQ: FMACU) (the “Company”) today announced the closing of its initial public offering of 11,200,000 units...
-
Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued...
-
SOLANA BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) today announced the closing of its previously announced private placement of 3,188,407 shares of...
-
RenovoCath® Generates $1.1 Million in 2025 Revenue in First Full Year of Commercialization Phase III TIGeR-PaC Trial on Track for Enrollment Completion by the Middle of 2026, and Final Data...
-
VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) -- Four hostile nations are already embedded inside America's critical infrastructure, quietly pre-positioned to flip the switch during a...
-
Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the...